Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
480
datasets available to search
ShareScore release 0.7.1
Dataset results
480 results for “Hormone Receptors”
Comparing Endocrine Therapy Combined With High-Dose Palbociclib and Hydroxychloroquine to Endocrine Therapy Combined With Standard-Dose Palbociclib for Hormone Receptor-Positive and HER2-Negative Adva
ClinicalTrials.gov study NCT07061717. IPD Sharing: NO. Countries: 1. Publications: 0.
Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy
ClinicalTrials.gov study NCT02414776. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT00717015. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Pr
ClinicalTrials.gov study NCT05801705. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer
ClinicalTrials.gov study NCT01857193. IPD Sharing: NO. Countries: 5. Publications: 0.
RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer
ClinicalTrials.gov study NCT01208441. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.
ClinicalTrials.gov study NCT05613504. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer
ClinicalTrials.gov study NCT00171808. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT04481113. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine
ClinicalTrials.gov study NCT04968964. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT00615524. IPD Sharing: Not stated. Countries: 1. Publications: 0.
This Clinical Trial is a Retrospective, Multicenter Cohort Study Evaluating the Real-world Characteristics and Risk of Disease Recurrence in Hormone Receptor-positive, HER2-negative Early Breast Cance
ClinicalTrials.gov study NCT07309887. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT05467891. IPD Sharing: NO. Countries: 1. Publications: 0.
Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.
ClinicalTrials.gov study NCT03283384. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer
ClinicalTrials.gov study NCT03128619. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Follicle Stimulating Hormone (FSH) Receptor Polymorphisms in In-Vitro Fertilization Cycles.
ClinicalTrials.gov study NCT01002885. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Feasibility Study of Topical Cannabinoids for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in Adults With Hormone Receptor-Positive Breast Cancer (CanAroma)
ClinicalTrials.gov study NCT05935891. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction
ClinicalTrials.gov study NCT07288138. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety Study of EG1206A (EirGenix' Pertuzumab) Compared With EU-sourced Perjeta® (Pertuzumab) in Patients With HER2-positive Hormone Receptor Negative Early Breast Cancer.
ClinicalTrials.gov study NCT06884254. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT00146601. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.